Literature DB >> 25044100

Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it means.

Sudharshan Hariharan1, Mary Ross Southworth, Rajanikanth Madabushi.   

Abstract

Entities:  

Keywords:  cardiovascular (CAR); clinical pharmacology (CPH); drug interactions; pharmacogenomics; pharmacokinetics and drug metabolism

Mesh:

Substances:

Year:  2014        PMID: 25044100     DOI: 10.1002/jcph.337

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  4 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients.

Authors:  Juntao Xie; Qingui Chen; Dejian He
Journal:  Front Cardiovasc Med       Date:  2022-07-04

3.  Major Depression as a Complicating Factor for Acute Coronary SyndromeReply.

Authors:  Levent Cerit
Journal:  Arq Bras Cardiol       Date:  2017-09       Impact factor: 2.000

Review 4.  Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis.

Authors:  Bo Huang; De-Jun Cui; Ying Ren; Bin Han; Da-Ping Yang; Xun Zhao
Journal:  J Res Med Sci       Date:  2017-09-26       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.